Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01804179 · ClinicalTrials.gov registry record · NA
Colorectal Cancer Awareness, Research, Education and Screening (CARES)
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 514
- Enrollment target
NCT01804179: Completed NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT01804179 is a NA study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 514 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01804179, a NA study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 514 participants
- Enrollment target
Study Summary
There are two parts to this study: (1) an information gathering phase leading to the development of new educational materials; and (2) a study to test the newly developed material. The information gathering phase has been completed. The purpose of this part of the research study is to test the usefulness and acceptability of new educational materials investigators have developed. Investigators will compare the new educational material to another widely available educational brochure. The goal is to see if the new educational material will change knowledge and behaviors about colorectal cancer and colorectal screening.
Primary Outcome
Investigators will measure uptake of I-FOBT/FIT as any completed kit within 180 days of delivery of the intervention. That is, the proportion of participants who return a sampled kit by the 6 month assessment (investigators expect most kits to be returned much sooner) for calculation of the primary screening endpoint. I-FOBT/FIT use will be compared (CARES vs. SI).
Interventions
- OTHER Immunochemical Fecal Occult Blood Test (I-FOBT) Kit
- OTHER Standard Intervention (SI) Educational Materials
- OTHER CARES Intervention Educational Materials
- OTHER Baseline Visit Survey
- OTHER Follow-up Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 514 participants |
| Start Date | 2011-02-11 |
| Est. Completion | 2022-09-09 |
| Phase | NA |
What the finished NCT01804179 record still lists
NCT01804179 is an interventional study that assigns participants to a tested intervention. The registered 514 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower).
The record links to 0 conditions, and to 5 interventions - of which Immunochemical Fecal Occult Blood Test (I-FOBT) Kit is the first listed.
NCT01804179 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01804179 about?
NCT01804179 is a clinical study titled "Colorectal Cancer Awareness, Research, Education and Screening (CARES)". There are two parts to this study: (1) an information gathering phase leading to the development of new educational materials; and (2) a study to test the newly developed material. The information gathering phase has been completed. The purpose of this part of the research study is to test the usefu...
What is the current status of trial NCT01804179?
This trial is currently completed. It is a NA study. The enrollment target is 514 participants. The study started on 2011-02-11. Estimated completion is 2022-09-09.
What interventions are being tested in trial NCT01804179?
The interventions under investigation include: Immunochemical Fecal Occult Blood Test (I-FOBT) Kit (OTHER), Standard Intervention (SI) Educational Materials (OTHER), CARES Intervention Educational Materials (OTHER), Baseline Visit Survey (OTHER), Follow-up Questionnaire (OTHER).
Who is sponsoring clinical trial NCT01804179?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01804179's enrollment target sits among peer trials
514 192nd of 2000 higher than 1,809 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05691244 · 514 participants · Phase 3
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
- NCT06585488 · 514 participants · Phase 1
A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification
- NCT06716606 · 514 participants · Phase 3
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
- NCT05577819 · 515 participants · NA
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI